Radiopotentiation of enzalutamide over human prostate cancer cells as assessed by real-time cell monitoring
ConclusionsThese results provide evidence that the enzalutamide/radiotherapy combination could maximize therapeutic responses in patients with enzalutamide-sensitive prostate cancer.
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research
More News: Androgen Independent Prostate Cancer | Cancer | Cancer & Oncology | Carcinoma | Prostate Cancer